# Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium

> **NCT02589366** · PHASE1 · TERMINATED · sponsor: **University of California, San Diego** · enrollment: 2 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** Lymphoseek plus Vital Blue Dye

## Key facts

- **NCT ID:** NCT02589366
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2018-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02589366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02589366, "Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02589366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*